Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma.

Ronkainen H, Kauppila S, Hirvikoski P, Vaarala MH.

J Exp Clin Cancer Res. 2010 Jan 14;29:2. doi: 10.1186/1756-9966-29-2.

2.

Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.

Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma VM.

J Clin Pathol. 2006 May;59(5):460-7. Epub 2006 Feb 3.

3.

Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.

Choi YS, Shim YM, Kim SH, Son DS, Lee HS, Kim GY, Han J, Kim J.

Eur J Cardiothorac Surg. 2003 Sep;24(3):441-9.

PMID:
12965318
4.

Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.

Chetty R, Serra S, Asa SL.

Am J Surg Pathol. 2008 Mar;32(3):413-9. doi: 10.1097/PAS.0b013e31813547f8.

PMID:
18300809
5.

An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.

Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, Robertson JF, Blamey RW, Ellis IO.

J Pathol. 1999 Apr;187(5):523-9.

PMID:
10398116
6.

Loss of E-cadherin and beta-catenin is correlated with poor prognosis of ampullary neoplasms.

Hsu HP, Shan YS, Jin YT, Lai MD, Lin PW.

J Surg Oncol. 2010 Apr 1;101(5):356-62. doi: 10.1002/jso.21493.

PMID:
20119975
8.

Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.

Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, Debruyne FM, Bringuier PP.

Cancer Res. 1996 Sep 15;56(18):4154-8.

9.
10.

Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.

Chen S, Liu J, Li G, Mo F, Xu X, Zhang T, Zhang X, Li J, Han X, Sun Y.

Scand J Gastroenterol. 2008;43(4):456-64. doi: 10.1080/00365520701785194.

PMID:
18365911
11.

The complementary role of beta-catenin in diagnosing various subtypes of renal cell carcinomas and its up-regulation in conventional renal cell carcinomas with high nuclear grades.

Guo L, Kuroda N, Miyazaki E, Hayashi Y, Toi M, Naruse K, Hiroi M, Ashida S, Shuin T, Enzan H.

Oncol Rep. 2001 May-Jun;8(3):521-6.

PMID:
11295073
12.

Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancer.

Garcia del Muro X, Torregrosa A, Muñoz J, Castellsagué X, Condom E, Vigués F, Arance A, Fabra A, Germà JR.

Eur J Cancer. 2000 Feb;36(3):357-62.

PMID:
10708937
13.

[Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].

Bae SH, Jung ES, Park YM, Jang JW, Choi JY, Cho SH, Yoon SK, Ahn BM, Cha SB, Chung KW, Sun HS, Park DH, Kim BK, Kim DG.

Taehan Kan Hakhoe Chi. 2002 Sep;8(3):297-303. Korean.

14.

Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.

Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G.

Cancer. 2005 Mar 15;103(6):1154-64.

15.
16.

The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors.

Pagaki E, Patsouris E, Gonidi M, Athanassiadou AM, Maurikakis M, Athanassiades P, Chelidonis G, Athanassiadou P.

Diagn Cytopathol. 2010 Jun;38(6):419-24. doi: 10.1002/dc.21188.

PMID:
20474081
17.

The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma.

Aaltomaa S, Lipponen P, Kärjä V, Lundstedt S, Lappi J, Kosma VM.

Anticancer Res. 2004 Jul-Aug;24(4):2407-13.

18.

Beta-catenin and E-cadherin tissue "content" as prognostic markers in left-side colorectal cancer.

Martinez NP, Kanno DT, Pereira JA, Cardinalli IA, Priolli DG.

Cancer Biomark. 2010-2011;8(3):129-35. doi: 10.3233/DMA-2011-0843.

PMID:
22012768
19.

Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.

Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, Shimazaki J, Yoshimi F, Fukao K.

Clin Cancer Res. 2002 Feb;8(2):450-6.

20.

The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.

van Oort IM, Tomita K, van Bokhoven A, Bussemakers MJ, Kiemeney LA, Karthaus HF, Witjes JA, Schalken JA.

Prostate. 2007 Sep 15;67(13):1432-8.

PMID:
17639504

Supplemental Content

Support Center